Combined in silico and in vitro analysis of pharmacoresistant sodium channel mutations in pediatric epileptic encephalopathies
Combined in silico and in vitro analysis of pharmacoresistant sodium channel mutations in pediatric epileptic encephalopathies
批准号:
364464
负责人:
Liang David Y
金额:
$0.36万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-01-01 至 2017-05-01
中文摘要
在这个项目中,实习生扩展了他的计算机药物对接经验,并检查了一个新开发的同源模型。该项目的第一部分将允许实习生利用他的计算技能进行诱变,药物对接和基因工程。
英文摘要
In this project, the intern expands upon his in silico drug docking experience and examine a newly developed homology model. The first part of the project will allow the intern to utilize his computational skills to make mutagenesis, drug dockings and ene
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金